Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, dental products and immunoglobulins to the Nordic market.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.


We are proud!

2016-07-06

We are a part of the global movement to defeat diarrheal disease. That makes us proud! https://www.youtube.com/watch?feature=player_embedded&v=80POTZN88Ho  

Etvax® was presented at VASE Conference

2016-07-05

Last week scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other experts from across the globe met at PATHs VASE Conference. The common goal is to develop and introduce new enteric vaccines to defeat diarrhea. Our vaccine-candidate, Etvax®, was presented as the leading candidate in the field of ETEC. We, Scandinavian Biopharma, were […]

Our ETEC-story is told in ”European Biotechnology”

2015-11-18

In the editorial hardback book ”European Biotechnology” we tell our story and describe our role within the life science/ biotech industry. What makes us unique, what is our goals and research collaborations? We tell the story about the ETEC vaccine that will be an important tool to battle diarrheal disease. http://www.hornonline.com/books/european_biotechnology/#204         […]